39^th European Neurology Congress

Session 01: Neurodegenerative Disorders – Mechanisms and Therapeutic Approaches

Neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis, are increasingly recognized as major global health challenges due to their progressive nature and profound impact on patients’ cognitive and motor functions. These conditions are characterized by the gradual loss of neuronal structure and function, driven by complex mechanisms such as protein misfolding, mitochondrial dysfunction, oxidative stress, and neuroinflammation, with both genetic and environmental factors contributing to disease susceptibility. Recent advances in neuroimaging and biomarker discovery, including positron emission tomography, functional magnetic resonance imaging, and cerebrospinal fluid analysis, have enabled earlier diagnosis and improved monitoring of disease progression, allowing clinicians to implement timely and personalized interventions. Therapeutic strategies are evolving beyond symptomatic management, with disease-modifying approaches targeting pathological processes such as protein aggregation, neuronal death, and inflammatory pathways. Pharmacological treatments, including small molecules and biologics, are being investigated to slow disease progression, while non-pharmacological interventions such as cognitive rehabilitation, physical exercise, and lifestyle modifications are increasingly recognized for their role in enhancing quality of life and supporting functional independence. This session will provide a comprehensive overview of current research, emerging therapies, and evidence-based clinical management strategies, emphasizing the integration of diagnostic tools, personalized treatment plans, and multidisciplinary care approaches. Attendees will gain insights into the challenges of translating scientific discoveries into practical clinical applications, explore innovative approaches to patient care, and engage in discussions on optimizing outcomes for individuals affected by these debilitating disorders. The session aims to equip neurologists, researchers, and healthcare professionals with knowledge and strategies to advance understanding, improve patient care, and contribute to the development of future therapeutic solutions in the field of neurodegenerative diseases.

Session 02: Stroke and Vascular Neurology – Advances in Diagnosis and Management

Stroke and vascular neurological disorders remain leading causes of morbidity and mortality worldwide, presenting significant challenges for clinicians and healthcare systems. This session will focus on the latest advancements in understanding the pathophysiology, risk factors, diagnosis, and management of cerebrovascular diseases, including ischemic stroke, hemorrhagic stroke, transient ischemic attacks, and vascular dementia. Participants will explore the role of atherosclerosis, hypertension, diabetes, and lifestyle factors in stroke development, as well as emerging genetic and molecular insights that inform risk stratification and prevention strategies. Rapid diagnosis and intervention are critical to improving outcomes, and the session will highlight cutting-edge imaging modalities, including computed tomography angiography, perfusion imaging, magnetic resonance imaging, and ultrasound techniques, which enable timely identification of stroke type, localization, and severity. Advances in acute management, such as thrombolysis, endovascular thrombectomy, neurocritical care, and targeted rehabilitation strategies, will be discussed in detail, with a focus on individualized patient-centered approaches that maximize functional recovery. In addition, secondary prevention measures, including pharmacological therapies, lifestyle modifications, and long-term monitoring, will be examined to reduce recurrence and enhance quality of life. Attendees will also gain insights into emerging technologies, including telemedicine, wearable devices, and digital monitoring systems, which are transforming stroke care and follow-up. By combining clinical expertise, research findings, and practical case discussions, this session aims to provide a comprehensive understanding of vascular neurology, equipping neurologists, clinicians, and researchers with the knowledge and tools to optimize patient outcomes, implement evidence-based strategies, and contribute to advancing the field of stroke prevention, diagnosis, and therapy in both acute and long-term care settings.

Session 03: Epilepsy – Diagnosis, Management, and Emerging Therapies

Epilepsy is a complex neurological disorder characterized by recurrent, unprovoked seizures that affect millions of individuals worldwide, with significant impacts on quality of life, cognitive function, and social well-being. This session will provide an in-depth exploration of the latest advancements in the diagnosis, classification, and management of epilepsy across all age groups, from pediatric to adult patients. Participants will examine the role of modern neuroimaging techniques, including magnetic resonance imaging, functional imaging, and electroencephalography, in localizing seizure foci and guiding treatment decisions. The session will also focus on genetic and molecular discoveries that are shaping precision medicine approaches, enabling tailored therapies based on individual patient profiles. A comprehensive review of pharmacological treatments will be presented, including traditional antiepileptic drugs, novel agents, and combination therapies, alongside non-pharmacological interventions such as ketogenic diets, vagus nerve stimulation, and surgical procedures like resective and laser ablation techniques. Case studies and clinical experiences will illustrate the challenges of treatment-resistant epilepsy, highlighting strategies to optimize seizure control and minimize adverse effects. Additionally, emerging research in neuroinflammation, neuroplasticity, and targeted molecular therapies will be discussed as promising avenues for future interventions. Attendees will gain practical knowledge in developing personalized care plans, integrating multidisciplinary approaches, and implementing long-term monitoring to enhance patient outcomes. This session aims to equip neurologists, epileptologists, clinicians, and researchers with the most current evidence-based insights, fostering a deeper understanding of epilepsy pathophysiology, diagnostic strategies, therapeutic innovations, and the evolving landscape of patient-centered management to improve both clinical care and quality of life for individuals living with this challenging neurological disorder.

Session 04: Neuroimmunology and Inflammatory Disorders – Advances in Diagnosis and Treatment

Neuroimmunology is a rapidly evolving field that explores the role of the immune system in the development, progression, and treatment of neurological disorders, with autoimmune and inflammatory conditions such as multiple sclerosis, neuromyelitis optica spectrum disorders, autoimmune encephalitis, and myasthenia gravis posing significant clinical challenges. This session will provide a comprehensive overview of the mechanisms underlying immune-mediated neurological diseases, including the contributions of autoreactive lymphocytes, cytokine signaling, blood-brain barrier dysfunction, and genetic susceptibility. Participants will gain insights into the latest diagnostic advancements, such as magnetic resonance imaging, cerebrospinal fluid analysis, antibody testing, and emerging biomarkers that enable early and accurate identification of inflammatory neurological disorders. The session will also explore current and emerging therapeutic strategies, including immunomodulatory and immunosuppressive therapies, monoclonal antibodies, plasma exchange, and targeted biologics, with a focus on balancing efficacy and safety to improve long-term outcomes. Clinical management approaches, including individualized treatment planning, monitoring for disease activity, and strategies for relapse prevention, will be discussed, highlighting the importance of multidisciplinary care teams in optimizing patient health. Attendees will also examine challenges in managing complex and refractory cases, as well as the integration of research discoveries into clinical practice to advance personalized medicine. Case studies and interactive discussions will provide practical examples of diagnosis, treatment, and patient monitoring, emphasizing the translation of scientific knowledge into effective clinical care. By participating in this session, neurologists, researchers, immunologists, and healthcare professionals will enhance their understanding of the pathophysiology, diagnostic tools, and innovative therapeutic approaches in neuroimmunology, empowering them to improve patient outcomes, reduce disease burden, and contribute to the advancement of this dynamic and critically important field in modern neurology.

Session 05: Neuroimaging and Diagnostic Advances – Transforming Neurological Care

Neuroimaging has revolutionized the diagnosis, monitoring, and management of neurological disorders, providing unprecedented insights into brain structure, function, and pathology. This session will focus on the latest advancements in neuroimaging technologies, including magnetic resonance imaging, functional magnetic resonance imaging, diffusion tensor imaging, positron emission tomography, computed tomography, and advanced ultrasound techniques, which enable accurate visualization of neuronal and vascular structures, early detection of disease, and precise treatment planning. Participants will explore the role of imaging in a wide range of neurological conditions, such as neurodegenerative diseases, stroke, epilepsy, traumatic brain injury, tumors, and demyelinating disorders, emphasizing the integration of imaging findings with clinical evaluation to enhance diagnostic accuracy and patient outcomes. The session will also highlight innovations in image-guided interventions, intraoperative navigation, and real-time brain mapping that improve surgical precision and safety. Emerging digital tools, including artificial intelligence-based image analysis, machine learning algorithms, and automated detection systems, will be discussed for their potential to streamline diagnosis, predict disease progression, and support clinical decision-making. Attendees will gain practical knowledge on the selection of appropriate imaging modalities, interpretation of complex imaging data, and application of imaging biomarkers in research and clinical practice. Case studies and interactive demonstrations will provide hands-on perspectives, illustrating how advanced imaging technologies can guide treatment planning, monitor therapeutic response, and facilitate early intervention. By participating in this session, neurologists, radiologists, researchers, and healthcare professionals will enhance their understanding of cutting-edge neuroimaging tools, diagnostic strategies, and technological innovations, equipping them to apply these advances effectively in patient care, improve clinical outcomes, and contribute to the ongoing evolution of neuroscience and neurological practice.

Session 06: Neurorehabilitation and Patient-Centered Care – Enhancing Recovery and Quality of Life

Neurorehabilitation plays a critical role in improving functional outcomes, independence, and quality of life for patients recovering from neurological disorders, including stroke, traumatic brain injury, spinal cord injury, neurodegenerative diseases, and neuromuscular conditions. This session will provide an in-depth exploration of evidence-based rehabilitation strategies that integrate physical, cognitive, and psychosocial interventions tailored to individual patient needs. Participants will learn about advanced physiotherapy techniques, occupational therapy approaches, speech and language therapy, and cognitive rehabilitation programs that support functional recovery and promote neuroplasticity. The session will also highlight the role of assistive technologies, including robotics, exoskeletons, virtual reality, and adaptive devices, which enhance patient engagement, motivation, and therapy outcomes. Emphasis will be placed on multidisciplinary collaboration, involving neurologists, rehabilitation specialists, nurses, psychologists, and caregivers, to develop comprehensive and personalized care plans that address both physical and emotional aspects of recovery. Attendees will gain insights into designing effective rehabilitation protocols, monitoring progress, and optimizing long-term outcomes through continuous assessment and adjustment of therapeutic interventions. The session will also discuss strategies for caregiver support, patient education, and community reintegration, recognizing the importance of holistic care in promoting patient well-being and social participation. By participating in this session, healthcare professionals will acquire practical knowledge and tools to implement innovative rehabilitation techniques, enhance patient-centered care, and improve functional independence for individuals affected by neurological conditions. This session aims to empower clinicians, therapists, and researchers with strategies to bridge the gap between acute neurological treatment and long-term recovery, ensuring patients receive comprehensive support to achieve optimal health outcomes and a better quality of life.

Session 07: Pediatric Neurology – Disorders in Children

Pediatric neurology focuses on the diagnosis, treatment, and management of neurological disorders in infants, children, and adolescents, addressing conditions that range from developmental delays, cerebral palsy, and epilepsy to neurometabolic and neurogenetic disorders. This session will provide an in-depth exploration of the unique challenges in pediatric neurological care, emphasizing early diagnosis, intervention, and long-term management to optimize developmental outcomes and quality of life. Participants will gain insights into advanced diagnostic techniques, including pediatric-specific neuroimaging, electroencephalography, genetic testing, and metabolic assessments, which facilitate accurate identification of underlying neurological conditions. The session will also cover pharmacological management, including age-appropriate dosing, novel therapeutic agents, and the role of non-pharmacological interventions such as physiotherapy, occupational therapy, speech and language therapy, and cognitive rehabilitation, tailored to the needs of young patients. Emphasis will be placed on a multidisciplinary approach, integrating the expertise of neurologists, pediatricians, therapists, psychologists, and caregivers to provide comprehensive care that addresses both medical and developmental needs. Attendees will also explore strategies for managing chronic neurological conditions, monitoring developmental progress, and supporting families through education, counseling, and community resources. Emerging research in pediatric neuroimmunology, neurodevelopmental disorders, and precision medicine will be discussed, highlighting the potential for personalized interventions that improve long-term outcomes. Through case discussions, clinical experiences, and evidence-based practices, this session aims to equip healthcare professionals with practical knowledge and skills to enhance diagnostic accuracy, implement effective treatment strategies, and provide holistic, patient-centered care. By participating in this session, neurologists, pediatric specialists, therapists, and researchers will gain the tools to advance pediatric neurological care, improve patient outcomes, and support the overall health, development, and well-being of children affected by neurological disorders.

Session 08: Neurosurgical Innovations and Interventions – Precision and Technology in Practice

Neurosurgery has witnessed significant advancements in recent years, with innovations in minimally invasive techniques, image-guided procedures, robotic-assisted surgery, and intraoperative navigation transforming the management of complex neurological disorders. This session will provide an in-depth exploration of these cutting-edge approaches, focusing on surgical interventions for brain tumors, spinal disorders, cerebrovascular diseases, and functional neurosurgery. Participants will gain insights into preoperative planning, patient selection, and risk mitigation strategies, emphasizing the integration of advanced imaging modalities, including magnetic resonance imaging, computed tomography, and intraoperative neuronavigation, to enhance surgical precision and optimize outcomes. The session will also highlight emerging technologies such as stereotactic radiosurgery, endoscopic procedures, and robotic systems, which reduce invasiveness, minimize complications, and accelerate patient recovery. Case studies and clinical experiences will illustrate best practices, challenges in complex surgeries, and innovative solutions for improving functional outcomes while maintaining safety and efficacy. Attendees will explore postoperative care protocols, rehabilitation strategies, and long-term follow-up considerations to ensure comprehensive management of neurosurgical patients. Additionally, discussions will cover the integration of research and clinical practice, including novel therapeutic approaches, clinical trials, and the translation of experimental techniques into standard care. By participating in this session, neurosurgeons, neurologists, clinicians, and researchers will acquire practical knowledge, enhance their understanding of modern neurosurgical tools, and learn strategies to implement technology-driven interventions effectively. This session aims to empower healthcare professionals with the skills and insights needed to advance neurosurgical practice, improve patient safety, achieve superior clinical outcomes, and contribute to the ongoing evolution of neurological care through precision, innovation, and technological excellence.

Session 09: Neuropharmacology and Emerging Therapies – Innovations in Treatment

Neuropharmacology plays a critical role in the treatment of a wide range of neurological disorders, offering therapeutic strategies that target the underlying pathophysiology and aim to improve patient outcomes. This session will explore the latest advancements in drug development, including novel small molecules, biologics, and targeted therapies for conditions such as neurodegenerative diseases, epilepsy, stroke, multiple sclerosis, and neuropathic pain. Participants will gain insights into mechanisms of action, pharmacokinetics, and pharmacodynamics of emerging therapies, as well as challenges in optimizing efficacy while minimizing adverse effects. The session will also examine translational research and clinical trial design, highlighting how preclinical discoveries are being implemented in human studies to accelerate therapeutic innovation. Attendees will explore combination therapies, precision medicine approaches, and strategies for individualized treatment plans, ensuring that patients receive the most effective and personalized care. Special focus will be given to non-traditional interventions, including gene therapies, stem cell-based approaches, neuroprotective agents, and neuroregenerative strategies that offer potential to modify disease progression and restore neurological function. Discussions will also cover the integration of pharmacological and non-pharmacological treatments, patient adherence, and monitoring techniques to optimize long-term outcomes. By participating in this session, neurologists, pharmacologists, researchers, and healthcare professionals will enhance their understanding of emerging therapeutic landscapes, gain practical knowledge for clinical application, and explore future directions in neurological drug development. This session aims to equip participants with the tools to translate scientific advances into effective patient care, foster innovation in neurological therapeutics, and contribute to improving the quality of life for individuals living with complex neurological disorders.

Session 10: Neuroethics and Policy in Clinical Practice – Navigating Challenges in Neurology

Neuroethics addresses the complex ethical, legal, and social considerations that arise in neurological research and clinical practice, encompassing patient care, research conduct, and public policy. This session will explore topics such as informed consent, decision-making capacity, end-of-life care, and management of neurodegenerative diseases, where patients may have diminished autonomy. Participants will examine the ethical challenges related to emerging technologies, including neuroimaging, brain stimulation, gene therapies, and artificial intelligence applications, balancing innovation with patient safety, privacy, and equity of access. The session will also highlight policy considerations, including healthcare regulations, clinical guidelines, reimbursement, and the impact of socioeconomic factors on neurological care delivery. Case-based discussions will provide practical insights into resolving ethical dilemmas, addressing conflicts between patient and family preferences, and ensuring adherence to professional standards. Attendees will gain understanding of frameworks for ethical decision-making, strategies for navigating legal responsibilities, and the integration of ethical considerations into research design and clinical protocols. By engaging with these discussions, neurologists, clinicians, researchers, and policymakers will develop the skills to address ethical and regulatory challenges in a rapidly evolving neurological landscape, promoting responsible innovation, patient-centered care, and equitable healthcare practices.

Session 11: Cognitive Neurology and Dementia – Advances in Diagnosis and Management

Cognitive disorders, including Alzheimer’s disease, vascular dementia, frontotemporal dementia, and mild cognitive impairment, pose significant clinical and societal challenges. This session will explore the pathophysiology, early detection, and management strategies for cognitive decline, emphasizing both diagnostic and therapeutic innovations. Participants will gain insights into neuroimaging techniques, cerebrospinal fluid biomarkers, and neuropsychological assessments used for accurate diagnosis and disease monitoring. The session will cover pharmacological therapies aimed at slowing cognitive decline, as well as non-pharmacological interventions such as cognitive training, lifestyle modifications, and social engagement strategies that improve patient quality of life. Attendees will also explore emerging research in neuroinflammation, synaptic plasticity, and precision medicine, highlighting potential disease-modifying interventions. Practical discussions on multidisciplinary care, caregiver support, and long-term management will equip healthcare professionals with tools to address complex clinical scenarios. By participating in this session, neurologists, psychiatrists, geriatricians, and researchers will acquire knowledge and strategies to enhance patient outcomes, provide holistic care, and advance understanding of cognitive disorders in clinical practice.

Session 12: Neuro-Oncology – Advances in Brain and Spinal Tumor Management

Neuro-oncology focuses on the diagnosis, treatment, and management of primary and metastatic tumors of the brain and spinal cord. This session will provide a comprehensive overview of modern approaches to neuro-oncological care, including advances in surgical techniques, radiotherapy, chemotherapy, targeted therapies, and immunotherapies. Participants will learn about molecular profiling, biomarkers, and genetic analysis that inform personalized treatment strategies and prognosis. The session will also cover challenges in managing tumor-related complications, such as edema, seizures, and cognitive deficits, as well as strategies to improve patient quality of life. Case-based discussions will illustrate clinical decision-making, multidisciplinary collaboration, and the integration of emerging research into practical care plans. Attendees will gain insights into innovative interventions, clinical trial developments, and future directions in neuro-oncology that aim to improve survival rates and functional outcomes.

Session 13: Pain and Neuromodulation – Innovative Approaches to Chronic Neurological Pain

Chronic neurological pain, including neuropathic pain, migraine, and complex regional pain syndrome, significantly affects patient quality of life and functional independence. This session will explore mechanisms of neurological pain, diagnostic strategies, and modern therapeutic interventions. Participants will learn about pharmacological treatments, including novel analgesics, anticonvulsants, and neuromodulatory agents, as well as non-pharmacological approaches such as cognitive behavioral therapy, biofeedback, and complementary therapies. The session will emphasize neuromodulation techniques, including deep brain stimulation, spinal cord stimulation, peripheral nerve stimulation, and transcranial magnetic stimulation, highlighting their mechanisms, clinical applications, and outcomes. Case studies will provide practical examples of pain management strategies, addressing complex and refractory cases. Attendees will gain knowledge to optimize patient-centered care, improve symptom management, and enhance overall quality of life for individuals suffering from chronic neurological pain.

Session 14: Sleep and Circadian Neurology – Understanding Brain Function and Disorders

Sleep and circadian rhythm disorders, including insomnia, sleep apnea, narcolepsy, restless leg syndrome, and circadian rhythm disruptions, have profound impacts on neurological health, cognitive performance, and overall well-being. This session will provide insights into the neurobiological mechanisms underlying sleep regulation, the interplay between sleep and neurodegenerative or psychiatric disorders, and the consequences of sleep disturbances on brain function. Participants will explore diagnostic tools such as polysomnography, actigraphy, and neuroimaging, along with emerging biomarkers for sleep-related neurological conditions. Therapeutic approaches, including pharmacological treatments, cognitive behavioral therapy for insomnia, chronotherapy, and lifestyle modifications, will be discussed in depth. Attendees will also examine the role of technology in monitoring sleep patterns, improving adherence, and optimizing interventions. By participating in this session, neurologists, sleep specialists, researchers, and healthcare professionals will gain comprehensive knowledge of sleep and circadian neurology, enabling them to implement effective diagnostic and therapeutic strategies that improve patient outcomes, brain health, and quality of life.

Session 15: Movement Disorders – Diagnosis and Therapeutic Strategies

Movement disorders, including Parkinson’s disease, dystonia, essential tremor, and chorea, represent a significant area of neurological practice due to their impact on motor function, daily activities, and quality of life. This session will focus on the pathophysiology, clinical features, and differential diagnosis of various movement disorders, highlighting advances in genetic, molecular, and neuroimaging research that inform patient care. Participants will gain insights into pharmacological treatments, including dopaminergic therapy, anticholinergics, and emerging drugs targeting disease progression, as well as non-pharmacological interventions such as physiotherapy, deep brain stimulation, and other neuromodulation techniques. Case discussions and practical examples will illustrate individualized treatment planning, monitoring of therapeutic response, and management of complications. Attendees will also explore research on disease-modifying strategies and novel therapeutic approaches, emphasizing precision medicine and multidisciplinary care. By participating in this session, neurologists, movement disorder specialists, researchers, and healthcare professionals will acquire knowledge and tools to optimize clinical outcomes, improve functional independence, and enhance the quality of life for patients affected by movement disorders.

Session 16: Neurogenetics – Understanding Genetic Contributions in Neurological Disorders

Neurogenetics examines the role of genetic factors in neurological disorders, providing insights into disease mechanisms, risk stratification, and personalized treatment approaches. This session will explore inherited conditions, including muscular dystrophies, hereditary neuropathies, ataxias, epilepsy syndromes, and neurodegenerative disorders, with a focus on identifying pathogenic mutations and understanding gene-environment interactions. Participants will gain knowledge on modern genetic testing techniques, such as next-generation sequencing, whole-exome and whole-genome analysis, and gene panels, which allow accurate diagnosis and inform prognostic decisions. The session will also cover emerging therapies, including gene editing, RNA-based treatments, and targeted molecular interventions, highlighting their potential for disease modification. Attendees will learn about ethical considerations, counseling strategies, and the translation of genetic discoveries into clinical practice. Case studies and practical discussions will demonstrate real-world applications, equipping clinicians, researchers, and geneticists with the tools to integrate neurogenetic knowledge into patient care, advance personalized medicine, and contribute to the development of novel therapeutic strategies.

Session 17: Neuroinfectious Diseases – Emerging Challenges and Management

Neuroinfectious diseases, including viral, bacterial, fungal, and parasitic infections of the central and peripheral nervous systems, present unique diagnostic and therapeutic challenges. This session will explore the pathophysiology, clinical presentation, and complications of conditions such as meningitis, encephalitis, neurosyphilis, HIV-associated neurological disorders, and emerging infections with epidemic potential. Participants will gain insights into modern diagnostic tools, including cerebrospinal fluid analysis, neuroimaging, molecular diagnostics, and serological testing, which facilitate rapid identification and management of infections. Therapeutic approaches, including antimicrobial therapy, supportive care, immunomodulation, and management of complications, will be discussed. The session will also highlight preventive strategies, including vaccination, public health initiatives, and early intervention protocols. Attendees will explore case studies and clinical experiences that illustrate the complexities of diagnosis, management, and long-term follow-up. By participating in this session, neurologists, infectious disease specialists, researchers, and healthcare professionals will enhance their understanding of neuroinfectious disorders, develop practical skills to improve patient outcomes, and contribute to global efforts in disease prevention and control.

Session 18: Neurocritical Care – Managing Life-Threatening Neurological Conditions

Neurocritical care focuses on the acute management of patients with severe neurological conditions, including stroke, traumatic brain injury, status epilepticus, intracerebral hemorrhage, and central nervous system infections. This session will provide insights into advanced monitoring techniques, such as intracranial pressure measurement, continuous electroencephalography, cerebral perfusion monitoring, and multimodal imaging, which guide timely interventions and optimize patient outcomes. Participants will gain knowledge on ventilatory management, hemodynamic support, sedation strategies, and targeted therapies for neuroprotection. The session will also address ethical considerations, prognostication, and multidisciplinary collaboration involving neurologists, intensivists, nurses, and allied healthcare professionals. Case studies will illustrate challenges in managing complex neurocritical patients, highlighting best practices, evidence-based protocols, and strategies for improving survival and functional recovery. Attendees will leave with practical insights to enhance critical care skills, streamline decision-making, and implement innovative approaches in acute neurological management.

Session 19: Headache and Migraine – Diagnosis and Modern Therapeutics

Headache disorders, particularly migraine, tension-type headache, and cluster headache, are among the most prevalent neurological conditions worldwide, significantly affecting patient quality of life, productivity, and psychosocial well-being. This session will explore the underlying pathophysiology, clinical classification, and diagnostic approaches for headache disorders, emphasizing evidence-based assessment and personalized care. Participants will gain insights into pharmacological management, including preventive and acute therapies, emerging biologics, neuromodulation techniques, and non-pharmacological interventions such as lifestyle modifications, cognitive behavioral therapy, and biofeedback. The session will also highlight challenges in managing chronic and refractory headache disorders, strategies to reduce medication overuse, and approaches to enhance patient adherence and outcomes. Attendees will benefit from case discussions, practical guidelines, and updates on recent research, equipping neurologists, headache specialists, primary care physicians, and researchers with knowledge and tools to optimize patient-centered care and improve functional outcomes for individuals affected by headache and migraine disorders.

Session 20: Neurotechnology and Brain-Machine Interfaces – Innovations for Functional Restoration

Neurotechnology, including brain-machine interfaces, neural prosthetics, and neuromodulation devices, represents a rapidly evolving field with the potential to restore function, improve independence, and enhance quality of life for patients with neurological deficits. This session will explore the principles, mechanisms, and applications of emerging neurotechnologies in conditions such as spinal cord injury, stroke, neurodegenerative diseases, and motor disorders. Participants will gain insights into invasive and non-invasive interfaces, neurofeedback systems, and adaptive devices that facilitate communication, mobility, and cognitive enhancement. The session will also discuss translational research, clinical trials, and regulatory considerations, emphasizing the integration of technology with patient-centered care. Case studies will illustrate practical applications, challenges, and strategies for optimizing outcomes. Attendees will acquire knowledge to harness innovative neurotechnologies, advance clinical practice, and contribute to the development of solutions that restore neurological function and improve patient independence and quality of life.